Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Prokinetic macrolides reported by Abbott

Sep. 20, 1996

Second pivotal trial for Carrington's ulcerative colitis product

Sep. 20, 1996

Novel proton pump inhibitors from Dainippon

Sep. 20, 1996

Gastrointestinal R&D at Daiichi

Sep. 13, 1996

Toyama's gastrointestinal R&D

Sep. 13, 1996

Another Asian approval obtained for SciClone's Zadaxin

Sep. 13, 1996

Anticholestatic drug accepted for review in the treatment of primary biliary cirrhosis

Sep. 13, 1996

New agents for disorders of gastrointestinal motility

Sep. 13, 1996

VML-295 clinical update

Sep. 13, 1996

Evaluation of potential therapies in maintaining remission in Crohn's disease

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...